Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma

Pathology and Oncology Research

Volumn 17, Issue 4, 2011, Pages 955-963

  Stanczak, Aleksandra ^a,b   Stec, Rafal ^c   Bodnar, Lubomir ^c   Olszewski, Wojciech ^d   Cichowicz, Marzena ^c   Kozlowski, Wojciech ^c   Szczylik, Cezary ^c   Pietrucha, Tadeusz ^a   Wieczorek, Maciej ^b   Lamparska Przybysz, Monika ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Celon Pharma Ltd   (Poland)

^c MILITARY INSTITUTE OF MEDICINE   (Poland)

^d INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

catenin; Advanced colorectal carcinoma; E cadherin; Prognostic factor; Wnt signaling pathway; Wnt 1

Indexed keywords

BETA CATENIN; CARCINOEMBRYONIC ANTIGEN; UVOMORULIN; WNT1 PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ASSESSMENT; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

AGED; AGED, 80 AND OVER; BETA CATENIN; CADHERINS; CELL NUCLEUS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; WNT1 PROTEIN;

EID: 84855471274     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9409-4     Document Type: Article

References (47)

1. Ferlay J, Shin HR, Bray F, Forman D,Mathers C, Parkin DM(2010) GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer. http://globocan.iarc.fr. Cited 20 Sept 2010
2. Sant M, Allemani C, Santaquilani M, Knijn A,Marchesi F, Capocaccia R (2009) EUROCARE Working Group. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 45:931-91
3. American Joint Committee on Cancer (2010) Colon and rectum. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) AJCC Cancer Staging Manual, The Seventh Edition. Springer, New York
4. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979-94
5. Chen JS, Hsieh PS, Chiang JM, Yeh CY, Tsai WS, Tang R et al (2010) Clinical outcome of signet ring cell carcinoma and mucinous adenocarcinoma of the colon. Chang Gung Med J 33:51-7
6. Matsumoto K, Nakayama Y, Inoue Y, Minagawa N, Katsuki T, Shibao K et al (2007) Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Dis Colon Rectum 50:308-14 (Pubitemid 46393971)
7. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell 17:9-26
8. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-6 (Pubitemid 29180374)
9. Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T (1999) beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155:1033-8 (Pubitemid 29488909)
10. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509-12 (Pubitemid 28425575)
11. Zhang T, Otevrel T, Gao Z, Gao Z, Ehrlich SM, Fields JZ et al (2001) Evidence that APC regulates survivin expression: A possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61:8664-7 (Pubitemid 34013874)
12. Gavert N, Ben-Ze'ev A (2007) beta-Catenin signaling in biological control and cancer. J Cell Biochem 102:820-8 (Pubitemid 350036922)
13. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN et al (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235-7
14. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130-4 (Pubitemid 28183198)
15. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787-90 (Pubitemid 27136715)
16. Hugh TJ, Dillon SA, O'Dowd G, Getty B, Pignatelli M, Poston GJ et al (1999) beta-catenin expression in primary and metastatic colorectal carcinoma. Int J Cancer 82:504-11 (Pubitemid 29343448)
17. Hugh TJ, Dillon SA, Taylor BA, Pignatelli M, Poston GJ, Kinsella AR (1999) Cadherin-catenin expression in primary colorectal cancer: A survival analysis. Br J Cancer 80:1046-51 (Pubitemid 29233927)
18. Han SA, Chun H, Park CM, Kang SJ, Kim SH, Sohn D et al (2006) Prognostic significance of beta-catenin in colorectal cancer with liver metastasis. Clin Oncol (R Coll Radiol) 18:761-7 (Pubitemid 44645406)
19. Krzakowski M (ed) (2001) Onkologia kliniczna, 1st edn. Warsaw, Borgis Wydawnictwo Medyczne
20. Delektorskaya VV, Perevoshchikov AG, Golovkov DA, Kushlinskii NE (2005) Expression of E-cadherin, beta-catenin, and CD-44v6 cell adhesion molecules in primary tumors and metastases of colorectal adenocarcinoma. Bull Exp Biol Med 139:706-10 (Pubitemid 41372235)
21. Choi HN, Kim KR, Lee JH, Park HS, Jang KY, Chung MJ et al (2009) Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex. Oncol Rep 21:57-63
22. Filiz AI, Senol Z, Sucullu I, Kurt Y, Demirbas S, Levhi Akin M (2010) The survival effect of E-cadherin and catenins in colorectal carcinomas. Colorectal Dis 12:1223-30
23. El-Bahrawy MA, Poulsom R, Jeffery R, Talbot I, Alison MR (2001) The expression of E-cadherin and catenins in sporadic colorectal carcinoma. Hum Pathol 32:1216-24 (Pubitemid 33104433)
24. Schuhmacher C, Becker I, Oswald S, Atkinson MJ, Nekarda H, Becker KF et al (1999) Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterations. Virchows Arch 434:489-95 (Pubitemid 29281305)
25. Hahn-Strömberg V, Edvardsson H, Bodin L, Franzén L (2008) Disturbed expression of E-cadherin, beta-catenin and tight junction proteins in colon carcinoma is unrelated to growth pattern and genetic polymorphisms. APMIS 116:253-62 (Pubitemid 351499160)
26. Huiping C, Sigurgeirsdottir JR, Jonasson JG, Eiriksdottir G, Johannsdottir JT, Egilsson V et al (1999) Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer 81:1103-10
27. Huiping C, Kristjansdottir S, Jonasson JG, Magnusson J, Egilsson V, Ingvarsson S (2001) Alterations of E-cadherin and beta-catenin in gastric cancer. BMC Cancer 1:16
28. Truant SC, Gouyer VP, Leteurtre EA, Zerimech F, Huet GM, Pruvot FR (2008) E-cadherin and beta-catenin mRNA levels throughout colon cancer progression. J Surg Res 150:212-8
29. Avizienyte E, Wyke AW, Jones RJ, McLean GW, Westhoff MA, Brunton VG et al (2002) Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol 4:632-8
30. Ikeguchi M, Makino M, Kaibara N (2001) Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma. J Surg Oncol 77:201-7 (Pubitemid 32645776)
31. Miyamoto S, Endoh Y, Hasebe T, Ishii G, Kodama K, Goya M et al (2004) Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers. Oncol Rep 12:245-51
32. Elzagheid A, Buhmeida A, Korkeila E, Collan Y, Syrjanen K, Pyrhonen S (2008) Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma. World J Gastroenterol 14:3866-71
33. Vider BZ, Zimber A, Chastre E, Prevot S, Gespach C, Estlein D et al (1996) Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene 12:153-8 (Pubitemid 26041251)
34. Holcombe RF, Marsh JL, Waterman ML, Lin F, Milovanovic T, Truong T (2002) Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol 55:220-6
35. Khor TO, Gul YA, Ithnin H, Seow HF (2006) A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis 21:291-300 (Pubitemid 43880533)
36. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A et al (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665-669 (Pubitemid 21917200)
37. Nakamura Y, Nishisho I, Kinzler KW, Vogelstein B, Miyoshi Y, Miki Y et al (1992) Mutations of the APC (adenomatous polyposis coli) gene in FAP (familial polyposis coli) patients and in sporadic colorectal tumors. Tohoku J Exp Med 168:141-7
38. Varesco L, Gismondi V, James R, Robertson M, Grammatico P, Groden J et al (1993) Identification of APC gene mutations in Italian adenomatous polyposis coli patients by PCR-SSCP analysis. Am J Hum Genet 52:280-5 (Pubitemid 23072410)
39. Polakis P, Hart M, Rubinfeld B (1999) Defects in the regulation of beta-catenin in colorectal cancer. Adv Exp Med Biol 470:23-32
40. Joo M, Shahsafaei A, Odze RD (2009) Paneth cell differentiation in colonic epithelial neoplasms: Evidence for the role of the Apc/ beta-catenin/Tcf pathway. Hum Pathol 40:872-80
41. Chiang JM, Chou YH, Chen TC, Ng KF, Lin JL (2002) Nuclear beta-catenin expression is closely related to ulcerative growth of colorectal carcinoma. Br J Cancer 86:1124-9 (Pubitemid 34438085)
42. Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RA et al (2001) Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol 195:171-8 (Pubitemid 32899025)
43. Aamodt R, Bondi J, Andersen SN, Bukholm G, Bukholm IRK (2008) Expression of nuclear β-Catenin in rectal versus colonic cancers. Open Clin Cancer J 2:13-17
44. Wray CM, Ziogas A, Hinojosa MW, Le H, Stamos MJ, Zell JA (2009) Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis. Dis Colon Rectum 52:1359-66
45. Bufill JA (1990) Colorectal cancer: Evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 113:779-88 (Pubitemid 20369667)
46. Li FY, Lai MD (2009) Colorectal cancer, one entity or three. J Zhejiang Univ Sci B 10:219-29
47. Nilbert M, Planck M, Fernebro E, Borg A, Johnson A (1999) Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer. Eur J Cancer 35:942-5 (Pubitemid 29277129)